Abstract:Psoriasis is a chronic skin inflammation, characterized by impaired differentiation, hyperproliferation of keratinocytes involving pro-inflammatory factors interleukin (IL)-13/17A, tumor necrosis factor (TNE)-alpha, interferon (IFN)-gamma. Among the integrin family, alpha 5 is important for blood vessel formation, and beta 4 for proliferation, differentiation of keratinocytes. To investigate the expression and regulation of integrin alpha 5 and beta 4 in psoriatic keratinocytes. Skin biopsies were obtained from 14 psoriatic patients and 12 normal volunteers. We compared the immunolocalization and regulation of alpha 5 and beta 4 between the psoriatic and normal ones, before and after incubation with MEK/ERK pathway inhibitor U0126 by immunohistochemistry and western blot separately. Immunohistochemistry showed psoriatic keratinocytes had higher alpha 5 than normal ones. According to western blot, IL-17A and IL-13 increased normal keratinocytes' alpha 5 and beta 4 respectively, but psoriatic keratinocytes were the exact opposite. Incubated with U0126, normal keratinocytes' alpha 5 was enhanced by the 5 cytokines; while IL-13/17A, IFN-gamma suppressed beta 4. Psoriatic keratinocytes' alpha 5 was increased by IL-13/17A, decreased by IFN-gamma; but beta 4 increased by IL-17A, IFN-gamma. IL-13/17A, TNF-alpha, IFN-gamma regulate alpha 5 and beta 4 through ERK pathway whether normal or psoriasis. The normal and psoriatic keratinocytes respond to the

Differential Regulation of Integrin Alpha 5 and Beta 4 in Normal and Psoriatic Epidermal Keratinocytes